rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sandra A. Gardiner

Director

Company insider

Files Form 4 as: Director, Adagio Medical Holdings; Director, Lucira Health; CFO & EVP Admin. and Finance, Pulse Biosciences; EVP & Chief Financial Officer, Cutera; VP & Chief Financial Officer, Vermillion; Chief Financial Officer, Lipid Sciences Inc/.

In numbers

Trades disclosed
30
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
6
Companies where not an officer
2
First trade
28 Feb 2006
Last trade
16 Jun 2026
Last filed
12 Aug 2026

Companies traded

Where they are an officer
PLSE Pulse BiosciencesOfficer · Medical Devices · last 14 Dec 20210 buys · 0 sells
CuteraOfficer · last 12 Feb 20190 buys · 0 sells
VermillionOfficer · last 18 Mar 20110 buys · 0 sells
Lipid Sciences Inc/Officer · last 3 Dec 20070 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ADGM Adagio Medical HoldingsDirector · Medical Devices · last 16 Jun 20260 buys · 0 sells
Lucira HealthDirector · last 1 Jun 20220 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
16 Jun 2026filed 12 Aug 2026ADGM Adagio Medical Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code A—30,000 at $0.00filing
16 Jun 2026filed 12 Aug 2026ADGM Adagio Medical Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code A—30,000 at $0.00filing
20 Mar 2025filed 21 Mar 2025ADGM Adagio Medical Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code A—90,000 at $0.00filing
1 Jun 2022filed 3 Jun 2022Lucira Healthoption or derivativeSEC FORM 4 Code A—59,459 at $0.00filing
14 Dec 2021filed 28 Feb 2022PLSE Pulse Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—25,961 at $0.00filing
22 Mar 2021filed 24 Mar 2021PLSE Pulse Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—18,000 at $0.00filing
23 Feb 2021filed 24 Mar 2021PLSE Pulse Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—8,750 at $0.00filing
9 Dec 2020filed 24 Mar 2021PLSE Pulse Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—25,961 at $0.00filing
18 Nov 2019filed 19 Nov 2019PLSE Pulse Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—103,842 at $0.00filing
18 Nov 2019filed 19 Nov 2019PLSE Pulse Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—103,842 at $0.00filing
12 Feb 2019filed 14 Feb 2019CuteraSEC FORM 4 Code A—18,128 at $0.00filing
2 Jan 2019filed 3 Jan 2019CuteraSEC FORM 4 Code A—2,734 at $0.00filing
2 Jan 2019filed 3 Jan 2019CuteraSEC FORM 4 Code F$19K1,117 at $17.02filing
2 Jan 2019filed 3 Jan 2019CuteraSEC FORM 4 Code F$9,514559 at $17.02filing
15 Dec 2018filed 17 Dec 2018CuteraSEC FORM 4 Code F$12K704 at $16.52filing
1 Dec 2018filed 4 Dec 2018CuteraSEC FORM 4 Code F$9,061442 at $20.50filing
13 Feb 2018filed 15 Feb 2018CuteraSEC FORM 4 Code A—5,469 at $0.00filing
15 Dec 2017filed 19 Dec 2017CuteraSEC FORM 4 Code A—5,121 at $0.00filing
15 Dec 2017filed 19 Dec 2017CuteraSEC FORM 4 Code A—2,036 at $0.00filing
15 Dec 2017filed 19 Dec 2017Cuteraoption or derivativeSEC FORM 4 Code A—16,005 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

John StrahleyChief Financial Officer · Chief Financial Officer at Aspira Women's Health, filing Form 4 there in the last year
Liane Rae TeplitskyChief Operating Officer · Chief Operating Officer at Pulse Biosciences, filing Form 4 there in the last year
Jon SkinnerChief Financial Officer · Chief Financial Officer at Pulse Biosciences, filing Form 4 there in the last year
Maria SainzDirector · Director at Pulse Biosciences, filing Form 4 there in the last year
Mahkam ZanganehDirector · Director at Pulse Biosciences, filing Form 4 there in the last year